LIFE
Atyr Pharma, Inc.
A San Diego biotech developing medicines from tRNA synthetases, the enzymes best known for building proteins inside cells. Its lead drug candidate, efzofitimod, targets fibrosis and inflammation, such as scarring of the lungs. Founded in 2005 by scientists Paul Schimmel and Xiang-Lei Yang, it grew out of their discovery that these enzymes also act outside cells as signaling molecules — a twist that gives the company its name, taken from tyrosyl-tRNA synthetase.
CUSIP: 002120103HealthcareUS1 holder
Recent Activity
2019Q3
1 sell
-3.21M shares
-3.21M shares
2019Q1
1 buy
+1.83M shares(+131.9%)
+1.83M shares(+131.9%)
Loading more activity...